Economic Impact Associated With Pharmaceutical Interventions in Cardiovascular Disease

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

doi 10.5649/jjphcs.43.680

Full Text

Abstract

Available in

Date

Authors

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Related search

Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions

JAMA Internal Medicine
Internal Medicine
2016English

Benzene Exposure Is Associated With Cardiovascular Disease Risk

PLoS ONE
Multidisciplinary
2017English

Impact of Mendelian Inheritance in Cardiovascular Disease

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2010English

Plasma Pentraxin 3 Is Associated With Cardiovascular Disease in Hemodialysis Patients

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2011English

Modeling the Economic Impact of Interventions for Older Populations With Multimorbidity: A Method of Linking Multiple Single-Disease Models

Medical Decision Making
Health Policy
2019English

Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Economic Impact of Lyme Disease

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2006English

Cardiovascular Disease and Hypertension in Sub-Saharan Africa: Burden, Risk and Interventions

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2016English

Economic Evaluation of Interventions in Parkinson's Disease - A Systematic Literature Review

Movement Disorders Clinical Practice
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy